Skip to main content
Pixium Vision logo

Pixium Vision — Investor Relations & Filings

Ticker · ALPIX ISIN · FR001400JX97 LEI · 96950046OPLRLKKEOO08 PA Manufacturing
Open in API
Filings indexed 440 across all filing types
Latest filing 2014-07-17 Share Issue/Capital Cha…
Country FR France
Listing PA ALPIX

About Pixium Vision

https://www.pixium-vision.com/

Pixium Vision was a bioelectronics company that developed bionic vision systems to restore partial sight for patients with retinal diseases. Its core technology, the PRIMA System, is a photovoltaic subretinal implant designed to treat vision loss from advanced atrophic dry age-related macular degeneration (dry AMD). The system uses specialized glasses to project near-infrared light onto the implant, which converts the light into electrical signals to stimulate retinal cells and create a form of prosthetic vision. The company's assets, including the PRIMA technology and its ongoing European pivotal trial (PRIMAvera), were acquired by Science Corporation in late 2023. The trials and device manufacturing are now sponsored by La Science SAS.

Recent filings

Filing Released Lang Actions
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Share Issue/Capital Change Classification · 99% confidence The document is a press release dated July 17, 2014, announcing the successful completion of an Initial Public Offering (IPO) for Pixium Vision, including the exercise of the over-allotment option, raising a total of 39.5 million euros. It details the stabilization operations conducted by the stabilizing agent (Société Générale) and discusses the intended use of the raised funds for product development and commercial launch. This content directly relates to fundraising, capital structure changes, and the issuance of new shares during an offering. This aligns best with the 'Capital/Financing Update' category (CAP). It is not a full Annual Report (10-K), an Earnings Release (ER), or a simple announcement of a report (RPA).
2014-07-17 French
Communicated under the obligation to provide permanent information / Other communications
Share Issue/Capital Change Classification · 99% confidence The document is an announcement titled "Pixium Vision announces successful completion of its IPO with its overallotment option exercised". It details the total proceeds (€39.5 million) from the Initial Public Offering (IPO) and the subsequent exercise of the overallotment option, including stabilization trade details reported to the AMF (French market authority). This content directly relates to fundraising, capital structure changes, and the issuance of new shares during a financing event. This aligns perfectly with the definition of 'Capital/Financing Update' (CAP). It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), as it concerns a specific capital market transaction.
2014-07-17 English
Communicated under the obligation to provide permanent information / Other communications
Regulatory Filings Classification · 95% confidence The document is a press release dated July 2nd, 2014, announcing that Pixium Vision received the ISO 13485 certification for its medical devices (IRIS® and PRIMA Vision Restoration Systems). This announcement relates to quality management systems and regulatory compliance steps necessary for future product approval (CE mark). It is not a formal regulatory filing like a 10-K, an earnings release (ER), a dividend notice (DIV), or a management discussion (MDA). Since it is a specific announcement regarding quality/regulatory compliance steps for a medical device, it fits best under the general 'Regulatory Filings' category (RNS) as a miscellaneous regulatory/operational update, as there is no specific code for 'Quality Certification Announcement'. Given its nature as a press release detailing a specific operational milestone, RNS is the most appropriate fallback.
2014-07-02 English
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Regulatory Filings Classification · 95% confidence The document is a press release dated July 2, 2014, announcing that Pixium Vision received ISO 13485 certification for its vision restoration systems (IRIS® and PRIMA). This announcement details a significant operational/regulatory milestone (certification) which is crucial for future CE marking and commercialization. It is not a full financial report (10-K or IR), an earnings release (ER), a management discussion (MDA), or a formal proxy/voting document. Since it is an announcement of a specific, non-financial regulatory/quality achievement that impacts the company's product pathway, it fits best under the general 'Regulatory Filings' (RNS) category, as it is a formal regulatory/quality update that doesn't align with the more specific categories like DIRS, DIV, or CAP. Given the length and content, it is a substantive announcement, not just a notice of publication (RPA).
2014-07-02 French
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Regulatory Filings Classification · 95% confidence The document is a press release dated June 24, 2014, announcing that Pixium Vision is eligible for the French PEA-PME (a specific type of equity savings plan). It details the company's status regarding French financial regulations concerning SME eligibility. This type of announcement, which relates to corporate status, financing eligibility, or general corporate news not covered by specific financial reporting codes (like 10-K, ER, or DIV), fits best under the general 'Regulatory Filings' category (RNS) as a miscellaneous regulatory/corporate update, or potentially 'Capital/Financing Update' (CAP) due to the nature of the tax/investment eligibility. Given that it is a specific announcement about regulatory eligibility rather than a financing event (like issuing shares or debt), RNS is a strong candidate. However, since it directly relates to the structure and benefits associated with holding the company's shares for investment purposes, it is a form of capital/financing structure information. Comparing the definitions, 'CAP' covers 'Updates on company fundraising, financing activities, or capital structure changes.' Eligibility for a tax-advantaged investment vehicle like PEA-PME is a change/update to the capital structure from an investor eligibility standpoint. Since RNS is the fallback, and this is a specific corporate status update, I will lean towards RNS as it is a general regulatory announcement that doesn't fit the core definitions of the other codes perfectly, although it has elements of CAP. Given the context of French regulatory announcements, RNS (Regulatory Filings) is the most appropriate catch-all for non-standard corporate news releases.
2014-06-24 French

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.